4//SEC Filing
Bailey Sue 4
Accession 0001567619-18-007116
CIK 0001367644other
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 4:41 PM ET
Size
23.4 KB
Accession
0001567619-18-007116
Insider Transaction Report
Form 4
Bailey Sue
Director
Transactions
- Exercise/Conversion
Common Stock
2018-11-27$20.08/sh+1,579$31,706→ 50,551 total - Sale
Common Stock
2018-11-27$69.62/sh−1,579$109,930→ 48,972 total - Exercise/Conversion
Common Stock
2018-11-27$13.00/sh+4,736$61,568→ 53,708 total - Sale
Common Stock
2018-11-27$69.62/sh−3,158$219,859→ 48,972 total - Exercise/Conversion
Stock Option (Right to buy)
2018-11-27−4,736→ 0 totalExercise: $13.00Exp: 2020-05-22→ Common Stock (4,736 underlying) - Exercise/Conversion
Stock Option (Right to buy)
2018-11-27−8,244→ 0 totalExercise: $18.64Exp: 2021-05-21→ Common Stock (8,244 underlying) - Sale
Common Stock
2018-11-27$69.62/sh−8,244$573,945→ 48,972 total - Exercise/Conversion
Stock Option (Right to buy)
2018-11-27−1,579→ 0 totalExercise: $20.08Exp: 2021-05-18→ Common Stock (1,579 underlying) - Exercise/Conversion
Common Stock
2018-11-27$18.64/sh+8,244$153,668→ 57,216 total - Sale
Common Stock
2018-11-27$69.62/sh−4,736$329,719→ 48,972 total - Exercise/Conversion
Common Stock
2018-11-27$13.37/sh+3,158$42,222→ 52,130 total - Exercise/Conversion
Stock Option (Right to buy)
2018-11-27−3,158→ 0 totalExercise: $13.37Exp: 2019-05-16→ Common Stock (3,158 underlying)
Footnotes (3)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.50 to $70.05, inclusive.
- [F2]Consists of an option granted under the company's stock incentive plan as amended and restated.
- [F3]The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.
Documents
Issuer
Emergent BioSolutions Inc.
CIK 0001367644
Entity typeother
Related Parties
1- filerCIK 0001403769
Filing Metadata
- Form type
- 4
- Filed
- Nov 28, 7:00 PM ET
- Accepted
- Nov 29, 4:41 PM ET
- Size
- 23.4 KB